[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-bis[[2-[(2-amino-3-methyl-butanoyl)amino]acetyl]oxy]-10,13-dimethyl-17-[(1R)-1-methyl-4-oxo-4-[[1-[3-[4-[[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-tris[[2-[(2-amino-3-methyl-butanoyl)amino]acetyl]oxy]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]methyl]triazol-1-yl]propyl]triazol-4-yl]methylamino]butyl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]2-[(2-amino-3-methyl-butanoyl)amino]acetate hexahydrochloride

ID: ALA5180522

Chembl Id: CHEMBL5180522

PubChem CID: 168272807

Max Phase: Preclinical

Molecular Formula: C99H170Cl6N20O20

Molecular Weight: 1954.52

Names and Identifiers

Canonical SMILES:  CC(C)C(N)C(=O)NCC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](C1)C[C@@H](OC(=O)CNC(=O)C(N)C(C)C)[C@@H]1[C@@H]2C[C@H](OC(=O)CNC(=O)C(N)C(C)C)[C@]2(C)[C@@H]([C@H](C)CCC(=O)NCc3cn(CCCn4cc(CNC(=O)CC[C@@H](C)[C@H]5CC[C@H]6[C@@H]7[C@H](OC(=O)CNC(=O)C(N)C(C)C)C[C@@H]8C[C@H](OC(=O)CNC(=O)C(N)C(C)C)CC[C@]8(C)[C@H]7C[C@H](OC(=O)CNC(=O)C(N)C(C)C)[C@]56C)nn4)nn3)CC[C@@H]12.Cl.Cl.Cl.Cl.Cl.Cl

Standard InChI:  InChI=1S/C99H164N20O20.6ClH/c1-50(2)84(100)90(128)108-42-76(122)134-62-28-30-96(15)58(34-62)36-70(136-78(124)44-110-92(130)86(102)52(5)6)82-66-24-22-64(98(66,17)72(38-68(82)96)138-80(126)46-112-94(132)88(104)54(9)10)56(13)20-26-74(120)106-40-60-48-118(116-114-60)32-19-33-119-49-61(115-117-119)41-107-75(121)27-21-57(14)65-23-25-67-83-69(39-73(99(65,67)18)139-81(127)47-113-95(133)89(105)55(11)12)97(16)31-29-63(135-77(123)43-109-91(129)85(101)51(3)4)35-59(97)37-71(83)137-79(125)45-111-93(131)87(103)53(7)8;;;;;;/h48-59,62-73,82-89H,19-47,100-105H2,1-18H3,(H,106,120)(H,107,121)(H,108,128)(H,109,129)(H,110,130)(H,111,131)(H,112,132)(H,113,133);6*1H/t56-,57-,58+,59+,62-,63-,64-,65-,66+,67+,68+,69+,70-,71-,72+,73+,82+,83+,84?,85?,86?,87?,88?,89?,96+,97+,98-,99-;;;;;;/m1....../s1

Standard InChI Key:  OJVWNCFSWNOHOL-UQPPUXSHSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 1954.52

Molecular Weight (Monoisotopic): 1953.2431

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Saini V, Mehta D, Gupta S, Kumar S, Rani P, Rana K, Rajput K, Jain D, Pal G, Aggarwal B, Pal S, Gupta SK, Kumar Y, Ramu VS, Bajaj A..  (2022)  Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid-Peptide Conjugates.,  65  (22.0): [PMID:36331380] [10.1021/acs.jmedchem.2c01293]

Source

Source(1):

• Scientific Literature